The certification of smallpox eradication and implications for guinea worm, poliomyelitis, and other diseases: confirming and maintaining a negative
- PMID: 22185832
- DOI: 10.1016/j.vaccine.2011.06.018
The certification of smallpox eradication and implications for guinea worm, poliomyelitis, and other diseases: confirming and maintaining a negative
Abstract
Rigorous, independent, confirmation of disease eradication is necessary to assure credibility of the claimed accomplishment. The criteria and procedures for formal certification of global disease freedom are based on the biological and epidemiological features of the pathogen and its manifestations. Certification activities by previously endemic and at-risk countries include comprehensive documentation focusing on surveillance, reports of national independent review groups, and special field surveys. National and regional results are reviewed by authoritative International Commissions (ICs) which verify the findings by field visits. The ICs present their results to an independent WHO-convened group ("Global Commission" for smallpox), members of which participate in field visits. When fully satisfied, the Global Commission makes conclusions and recommendations to the World Health Assembly (WHA). Smallpox was confirmed eradicated in 1980 by the WHA less than three years after the last naturally occurring case was detected. Dracunculiasis (guinea worm) freedom has been certified in 187 countries. Regional commissions have certified the Americas, Asia, and Europe polio-free; however, re-establishment of endemic foci in countries previously declared disease-free has created special challenges for completing this program. Post-eradication activities require attention to surveillance, maximum security of the microbial agent, and essential research to assure maintenance of disease freedom.
Copyright © 2011. Published by Elsevier Ltd.
Similar articles
-
The principles and feasibility of disease eradication.Vaccine. 2011 Dec 30;29 Suppl 4:D70-3. doi: 10.1016/j.vaccine.2011.04.006. Epub 2011 Dec 19. Vaccine. 2011. PMID: 22188936 Review.
-
The Emergency campaign for smallpox eradication from Somalia (1977-1979)--revisited.Vaccine. 2011 Dec 30;29 Suppl 4:D36-40. doi: 10.1016/j.vaccine.2011.05.039. Epub 2011 Dec 18. Vaccine. 2011. PMID: 22185834 Review.
-
Guinea worm (Dracunculiasis) eradication: update on progress and endgame challenges.Trans R Soc Trop Med Hyg. 2014 May;108(5):249-51. doi: 10.1093/trstmh/tru039. Epub 2014 Apr 2. Trans R Soc Trop Med Hyg. 2014. PMID: 24699360
-
The global polio eradication initiative: lessons learned and prospects for success.Vaccine. 2011 Dec 30;29 Suppl 4:D80-5. doi: 10.1016/j.vaccine.2011.10.005. Vaccine. 2011. PMID: 22486981 Review.
-
Dracunculiasis eradication and the legacy of the smallpox campaign: what's new and innovative? What's old and principled?Vaccine. 2011 Dec 30;29 Suppl 4:D86-90. doi: 10.1016/j.vaccine.2011.07.115. Epub 2011 Dec 18. Vaccine. 2011. PMID: 22185836 Review.
Cited by
-
Global control of COVID-19: good vaccines may not suffice.Rev Panam Salud Publica. 2021 Dec 10;45:e148. doi: 10.26633/RPSP.2021.148. eCollection 2021. Rev Panam Salud Publica. 2021. PMID: 34908811 Free PMC article.
-
Evaluation of the integrated disease surveillance and response system for infectious diseases control in northern Ghana.BMC Public Health. 2015 Feb 4;15:75. doi: 10.1186/s12889-015-1397-y. BMC Public Health. 2015. PMID: 25648630 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical